Familial Partial Lipodystrophy
8 clinical trials · Condition
◉ Watch Familial Partial Lipodystrophy
| Record | Firm | Date |
|---|---|---|
| A Study to Examine the Effects of the Leptin Receptor (LEPR) Agonist Antibody REGN4461 in Adult Patients With Familial Partial Lipodystrophy (FPLD) (NCT05088460) | Regeneron Pharmaceuticals | 2022-02-28 |
| Study of AKCEA-ANGPTL3-LRx (ISIS 703802) in Participants With Familial Partial Lipodystrophy (FPL) (NCT03514420) | Akcea Therapeutics | 2018-06-15 |
| Study of Gemcabene in Adults With FPLD (NCT03508687) | Elif Oral | 2018-03-13 |
| Phase 2 Study of Obeticholic Acid for Lipodystrophy Patients (NCT02430077) | Abhimanyu Garg | 2016-06-01 |
| The BROADEN Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Participants With Familial Partial Lipodystrophy (NCT02527343) | Akcea Therapeutics | 2015-12-28 |
| CLINICAL PROTOCOL to Investigate the Long-term Safety and Efficacy of Metreleptin in Various Forms of Partial Lipodystrophy (NCT02654977) | University of Michigan | 2015-09-29 |
Track Familial Partial Lipodystrophy automatically
Every clearance here is in the API, with alerts when new ones post.